Ionis製藥 IONS 深 滬
已收盤 09-19 16:00:00 美东时间
42.74
+0.380
+0.90%
華盛通- 最 高43.50
- 今 開42.88
- 成交量 165.55万股
- 最 低 42.38
- 昨 收 42.36
- 總市值 67.41亿
- 52周最高 54.4446
- 市盈率 靜 --
- 換手率 1.05%
- 52周最低 35.95
- 委 比 -80.00%
- 總股本 1.58亿
- 歷史最高 86.582
- 量 比 0.70
- 振 幅 2.64%
- 歷史最低 6.25
- 每 手 1
- 風險率 4.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Stock moves reflect downgrade for US economic growth outlook - Goldman
Equity rotations recently are reflecting a downgrade for the growth outlook on the US economy, but the S&P 500 (SP500) remains near its all-time high because of anticipated interest-rate cuts by the F...
09-16 03:48
Viterra Finance B.V. - ANNONCE
/NE PAS DIFFUSER, PUBLIER OU DISTRIBUER A) AUX ÉTATS-UNIS OU À TOUTE PERSONNE...
09-14 01:48
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Shares of Oracle Corporation (NYSE:ORCL) rose sharply in today's pre-market tra...
09-10 18:41
Reported Earlier, Ionis Prices $500.3M Public Offering Of 11.5M Common Shares At $43.50/Share
Ionis intends to use the net proceeds from the offering to fund its independent commercial launches, late-stage clinical programs, earlier pipeline programs, and research and development activities, as well as for
09-10 15:35
Ionis announces proposed public offering of common stock
Ionis Pharmaceuticals (NASDAQ:IONS) announced a proposed underwritten public offering of $500M of its common stock. Ionis intends to grant the underwriters a 30-day option to purchase up to an additio...
09-10 04:28
Biogen announces trial win for higher Spinraza doze
Biogen (NASDAQ:BIIB) on Wednesday announced that its Phase 2/3 DEVOTE study reached the primary endpoint for a higher dose of its flagship product, Spinraza, which is approved in the U.S. for the neur...
09-04 20:07
SOUTHWEST AIRLINES BRINGS BACK ITS LIMITED-TIME COMPANION PASS PROMOTION!
DALLAS, Sept. 3, 2024 /PRNewswire/ -- Southwest Airlines Co. (NYSE: LUV) announces the return of its highly-coveted Companion Pass® promotion. The airline's Companion Pass allows Rapid Rewar...
09-03 23:00
Ionis Pharmaceuticals’ Strong Position in the Market Post-Competitor Trial Analysis
Wells Fargo analyst Yanan Zhu assigned a Buy rating on Ionis Pharmaceuticals (I...
09-02 19:06
Royce Micro-Cap Trust (NYSE: RMT) as of Jul 31, 2024
NEW YORK, Aug. 28, 2024 /PRNewswire/ -- Average weekly trading volume of appr...
08-29 00:05
Ionis to present at upcoming investor conferences
CARLSBAD, Calif., Aug. 28, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor confer...
08-28 19:05
